| Univariate | Multivariate | ||||
Stage 1 + 2:a | HR | 95% CI | P | HR | 95% CI | P |
Gender |
|
|
|
|
|
|
Female (n = 124) | 1.00 | ref |
| 1.00 | ref |
|
Male (n = 165) | 1.88 | 1.35 - 2.60 | 0.0002 | 1.71 | 1.21 - 2.43 | 0.002 |
Age |
|
|
|
|
|
|
<70 (n = 135) | 1.00 | ref |
| 1.00 | ref |
|
≥70 (n = 154) | 2.75 | 1.98 - 3.82 | <0.001 | 1.69 | 1.14 - 2.49 | 0.009 |
Performance status |
|
|
|
|
|
|
0-1 (n = 233) | 1.00 | ref |
| 1.00 | ref |
|
2-4 (n = 56) | 6.06 | 4.17 - 8.81 | <0.001 | 2.29 | 1.40 - 3.74 | 0.0009 |
Stage 3:b |
|
|
|
|
|
|
Gender |
|
|
|
|
|
|
Female (n = 141) | 1.00 | ref |
| 1.00 | ref |
|
Male (n = 281) | 1.42 | 1.14 - 1.77 | 0.002 | 1.33 | 1.05 - 1.69 | 0.017 |
Age |
|
|
|
|
|
|
<70 (n = 177) | 1.00 | ref |
| 1.00 | ref |
|
≥70 (n = 245) | 1.53 | 1.24 - 1.89 | <0.001 | 0.85 | 0.67 - 1.08 | 0.188 |
Performance status |
|
|
|
|
|
|
0-1 (n = 239) | 1.00 | ref |
| 1.00 | ref |
|
2-4 (n = 183) | 3.52 | 2.83 - 4.39 | <0.001 | 2.06 | 1.60 - 2.65 | <0.001 |
Stage 4:c |
|
|
|
|
|
|
Gender |
|
|
|
|
|
|
Female (n = 222) | 1.00 | ref |
| 1.00 | ref |
|
Male (n = 298) | 1.09 | 0.91 - 1.30 | 0.350 | 1.00 | 0.83 - 1.20 | 0.968 |
Age |
|
|
|
|
|
|
<70 (n = 279) | 1.00 | ref |
| 1.00 | ref |
|
≥70 (n = 241) | 1.20 | 1.01 - 1.43 | 0.042 | 0.68 | 0.56 - 0.83 | 0.0002 |
Performance status |
|
|
|
|
|
|
0-1 (n = 167) | 1.00 | ref |
| 1.00 | ref |
|
2-4 (n = 353) | 3.19 | 2.61 - 3.88 | <0.001 | 2.80 | 2.25 - 3.47 | <0.001 |